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ABSTRACT 
Alcohol and drug abuse represent two of today’s greatest unsolved public health 
problems.  The dynorphin/kappa opioid receptor (KOR) system has been shown to mediate the 
increased rewarding effects of drugs of abuse and the increased anxiety and stress seen during 
alcohol withdrawal.  In the present study, we examined the role of the dynorphin/KOR system in 
the Bed Nucleus of the Stria Terminalis (BNST) in stress related behaviors using an animal 
model.  We stereotaxically injected mice with an inducible caspase construct to selectively 
destroy dynorphin cells in the BNST and tested mice using the elevated plus maze (EPM), open 
field, and forced swim stress (FSS) behavioral paradigms.  Our results show that under basal, 
non-stress conditions, ablating dynorphin from the BNST does not produce significant changes 
in behavior.  However, dynorphin and KORs may play an important role in mediating behavior 
following a stressful event (FSS).  Using Designer Receptors Exclusively Activated by Designer 
Drugs (DREADDs), we show that functionally inhibiting dynorphin neurons in the BNST may 
have an anxiogenic effect under stressful conditions faced in the FSS-EPM behavioral paradigm.  
These results, along with an ongoing set of behavioral experiments with the DREADD mice, 
may provide novel insight for the role of the dynorphin/KOR system in mediating the stress 
response relevant to alcohol and drug use disorders. 
 
INTRODUCTION 
Alcohol, drug use, and anxiety disorders represent significant unsolved public health 
problems.  Looking at alcohol specifically, 3.8% of all global deaths in 2004 were attributed to 
alcohol (Rehm, et al. 2009). Societal costs in the United States associated with these alcohol use 
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disorders were an estimated $148 billion in 1992 and rose to $223.5 billion by 2006 (Harwood, 
Fountain, & Livermore, 1998; Bouchery et al. 2011). A high co-morbidity has been shown 
between alcoholism and anxiety disorders, suggesting the possible presence of common 
mechanisms (Swendsen, 1998; Grant & Harford, 1995).  
Several brain regions have been implicated in these disorders; among them is the Bed 
Nucleus of the Stria Terminalis (BNST).  The BNST is a critical output region of the extended 
amygdala that receives cortical and limbic projections and itself projects to multiple brain 
regions involved in drug-seeking behaviors, alcohol withdrawal, and anxiety behaviors 
(Silberman and Winder, 2013).  Several members of the endogenous opioid system – a system 
known to mediate emotional and behavioral responses to stress – are expressed in the BNST and 
may be implicated in these behaviors.  Among those broadly expressed is the kappa opioid 
receptor and its ligand dynorphin (Poulin, 2009).  
Several studies have demonstrated a significant role of the dynorphin/KOR system in 
stress responses, addiction-related behaviors, and anxiety disorders (Bruchas, Land & Chavkin 
2010; Knoll & Carlezon 2010).  Stress causes a cascade leading to the release of dynorphin, 
which binds the kappa opioid receptor (Nabeshima, et al. 1992).  Activation of the 
dynorphin/KOR system has been shown to mediate the increased rewarding effects of cocaine 
and the increased anxiety and stress seen during alcohol withdrawal (McLaughlin, et al. 2003; 
Schank et al. 2012).  Furthermore, chronic stress is known to increase the likelihood of relapse 
into drugs and alcohol-seeking behavior (Sinha 2001) and can increase the risk of depression in 
addition to lowering overall quality of life
 
(Brown et al. 1989). 
While the dynorphin/KOR system has been implicated in many of the aforementioned 
disorders, its full role and specific mechanisms in the stress response and stress-induced 
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behaviors are not well understood. Better understanding these mechanisms may provide critical 
information about therapeutic targets involving the KOR and treatment strategies for alcoholism, 
drug addiction, and anxiety disorders. 
In the present study, we examine the necessity of the dynorphin/KOR system in stress 
related behaviors using an animal model. We selectively ablated dynorphin from the BNST 
through stereotaxic injection of an inducible caspase construct. This Cre-inducible caspase can 
only be cleaved by TEV, which is also packaged in the AAV vector. By injecting this construct 
into a dynorphin-Cre mouse, we can selectively induce cell apoptosis only in those neurons 
expressing Cre.  Additionally, we are undertaking a set of experiments using Designer Receptors 
Exclusively Activated by Designer Drugs (DREADDs) to alter the excitability of Cre neurons (in 
a dynorphin-Cre mouse) during stress. These DREADDs are excitatory or inhibitory engineered 
G-protein coupled receptors that are exclusively activated by inert synthetic ligands (Armbruster, 
et al. 2007).  We stereotaxically injected an inhibitory Gi coupled DREADD receptor into the 
BNST, which when activated by its synthetic ligand clozapine-N-oxide (CNO), causes 
hyperpolarization and decreased excitability of these Cre neurons, functionally inhibiting them.  
We hypothesize that upon induced apoptosis of dynorphin-Cre neurons (via flex caspase3) or 
functional inhibition of dynorphin-Cre neurons (via DREADDs) in the BNST, external stressors 
will unable to activate the local BNST KOR system, resulting in a less anxious phenotype as 
compared to control mice. 
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METHODS 
Animals used 
Adult male dynorphin-Cre mice were generated by the Krashes lab using recombineering 
techniques as previously described (Krashes, et al. 2014).  These dynorphin-Cre mice were 
crossed to wild-type littermates to produce the offspring used in this study.  All mice used were 
genotyped to affirm whether they were Cre+ before experimentation.  Cre+ males were used for 
all experiments excluding the Forced Swim-EPM experiments, for which wild-type dynorphin-
Cre male mice were used.  Mice were housed in cages with 2-3 littermates, water, and rodent 
chow.  The housing room had a 12-hour light/dark cycle.  All procedures were conducted in 
compliance with the Guide for the Care and Use of Laboratory Animals and approved by the 
Institutional Animal Care and Use Committee of the University of North Carolina. 
 
Stereotaxic Surgery 
Mice were anesthetized using inhaled isoflurane delivered through a stereotax.  Mice 
were placed on a heating pad to assist with thermoregulation.  The mice were stereotaxically 
injected with 500 nL DIO-hChR2 (control) or 500nL flex capase3 (experimental) bilaterally to 
the BNST (coordinated from Bregma: +0.90 medial/lateral, +0.27 anterior, -4.25 ventral).  The 
surgical incision was closed using VetBond.  The mice were subcutaneously injected with 1.0 ml 
0.9% saline after surgery to assist with blood loss and recovery.  Mice were provided with 
acetaminophen in their water pre- and post-operatively.  Mice were allowed to recover for 10 
days before performing behavioral experiments.  N=9 control mice and n=11 flex caspase mice 
were injected by Sakibul Huq. 
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Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) 
 Mice were stereotaxically injected, as described previously, with 300 nL AAV8/hSyn-
DIO-mCherry (control) or 300 nL AAV8/hSyn-DIO-hM4D (Gi)-mCherry bilaterally to the 
BNST (coordinated from Bregma: +0.80 medial/lateral, +0.29 anterior, -4.25 ventral).  
Coordinates and injection volume were adjusted from previous experiments to prevent spill-over 
of injected substance into neighboring brain regions.  N=8 control mice and n=8 DREADD mice 
were injected with appropriate substances by Sakibul Huq and Nicole Capik.  Mice were allowed 
to recover for three weeks to allow DREADD receptors to express.  They were injected with the 
synthetic ligand for the hM4D receptor, clozapine-N-oxide (CNO), 45 minutes before 
undergoing the Forced Swim Stress-Elevated Plus Maze (FSS-EPM) test described below.  
 
Elevated Plus Maze (EPM) 
An elevated plus maze was used that contains four arms elevated 1m above the floor.  
Two of the arms are open, meaning that there are no walls protecting the mice from falling off, 
and two arms are closed, with 7cm high walls protecting the mice from falling off.  A small 
square central area exists at the intersection of the four arms.  Mice were transported one-by-one 
from the main lab into the behavior room.  Each mouse was placed in the central area and its 
movement was recorded for five minutes using cameras above the experimental apparatus.  All 
elevated plus maze tests were performed by Sakibul Huq. 
 
Open Field (OF) 
An open field chamber within a black box containing an LED light was used; the 
chamber was a large white Plexiglas square box (without a ceiling) measuring 50cm x 50cm x 
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25cm.  Mice were transported one-by-one from the main lab into the behavior room.  Each 
mouse was placed into the center of the chamber and its movement was recorded for 30 minutes 
using cameras above the experimental apparatus.  All open field tests were performed by Sakibul 
Huq. 
 
Forced Swim Stress (FSS) 
Forced swim cylinders consisting of transparent Plexiglas measuring 20cm in diameter x 
40 cm high containing water (25
o
C) filled halfway to the top were used.  Mice were transported 
one-by-one from the main lab into the behavior room.  Each mouse was placed into the water in 
the cylinder and its movement (mobility vs. immobility) was recorded for six minutes using 
cameras above the experimental apparatus.  Two mice were run at a time; the two cylinders used 
were separated by an opaque black wall.  After each trial, the mice were placed under a heat 
lamp for four minutes or until dry.  All FSS tests were performed by Sakibul Huq. 
 
Forced Swim-Elevated Plus Maze (FSS-EPM) 
Mice were placed in Forced Swim Stress cylinders, as described previously, for 5 
minutes and allowed to rest under a heat lamp for 4 minutes.  Mice were then immediately 
placed on the Elevated Plus Maze for 5 minutes and analyzed as described previously using 
EthoVision software.  All FSS-EPM experiments were performed by Sakibul Huq. 
 
CNO Injection and FSS-EPM  
N=5 dynorphin-Cre DREADD mice and n=4 control mice were given systemic 
intraperitoneal (IP) injections of clozapine-N-oxide (CNO) 45 minutes prior to the FSS test in the 
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FSS-EPM behavioral paradigm.  CNO was administered at 10 ml/kg.  All CNO injections and 
subsequent FSS-EPM experiments were performed by Sakibul Huq. 
 
Preparation of Brain Slices 
Perfusions were conducted as previously described by the Kash Lab (Li, et al. 2013). All 
perfusions were performed by Alexis Kendra. 
All brains were sliced into m slices using a vibratome.  Slices were placed in well 
plates containing 50% Phosphate Buffered Saline (PBS)/50% glycerol solution.  All slicing was 
performed by Sakibul Huq. 
Immunohistochemistry using Cre staining is currently being performed on all brain slices 
to verify the success of stereotaxic surgeries.  The IHC protocol for Cre staining was piloted and 
designed by Ayumi Nakamura in the lab of Mohanish Deshmukh (UNC Neurobiology).  The 
protocol involves a primary antibody step, a secondary antibody step, and mounting onto slides 
with DAPI.  All immunohistochemistry will be performed by Nicole Capik. 
 
Analysis of Data 
Elevated plus maze, open field, forced swim stress, and FSS-EPM tests were analyzed 
using Ethovision software.  The software tracks the movement of the mice during the different 
behavioral testing paradigms and exports the raw data to Microsoft Excel.  Excel was then used 
to create the graphs shown in the “Results” section.  The forced swim stress experiments were 
analyzed by Sakibul Huq.  The elevated plus maze, open field, and FSS-EPM experiments were 
analyzed by Sakibul Huq and Nicole Capik.  
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RESULTS 
 
Figures 1-5 below represent the data gathered from the behavioral paradigms used to test 
for differences between control and experimental mice using the flex caspase and DREADD 
technological approaches.  Sample sizes (n values) are shown on the columns in the figures.  In 
Figure 1, the time spent in the open arms of the elevated plus maze is measured for control (n=9) 
and experimental (n=11) mice.  The control mice spent an average of 40.7 seconds (out of 300 
seconds) in the open arms, while the experimental mice spent an average of 44.6 seconds in the 
open arms.  These times are almost equal, showing no difference between the control and 
experimental groups.   
Figure 2 displays the amount of time spent in the center of the Open Field chamber for 
the control (n=8) and experimental (n=10) mice.  In the center of the chamber, the control mice 
spent an average of 96.4 seconds while the experimental mice spent an average of 123.8 seconds 
(out of 1800 seconds).  There is no statistically significant difference between the control and 
experimental groups. 
Figure 3 displays the percent time spent immobile in the Forced Swim Stress cylinder for 
the control (n=8) and experimental (n=11) mice.  The control mice were immobile 74.5% of the 
time on average while the experimental mice were immobile for 71.3% of the time on average.  
There is no statistically significant difference between the control and experimental groups. 
 Figure 4 displays time spent in the open arms and entries into the open arms for wild-type 
mice that underwent the FSS-EPM behavioral paradigm.  Unlike data shown in Figures 1-3, no 
surgeries were performed on these mice.  As seen in Figure 4a, Control mice spent 76.2 seconds 
in the open arms, and FSS mice spent 51.8 seconds in the open arms, on average.  This is not a 
statistically significant difference.  Figure 4b shows that control mice entered the open arms 8.2 
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times, and FSS mice entered the open arms 3.25 times, on average.  These results are statistically 
significant (p<0.05) for the control vs. FSS groups.   
 Figure 5 shows FSS-EPM data for DREADD and control mice that underwent the FSS-
EPM behavioral paradigm.  The control mice spent an average of 60.0 seconds in the open arms 
of the EPM, while the DREADD mice spent an average of 38.0 seconds in the open arms of the 
EPM.  The control mice entered the open arms an average of 7.0 times, while the DREADD 
mice entered the open arms an average of 3.6 times; this was a statistically significant difference 
(p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Open Field Time Spent in Center of Chamber 
Figure 2. Time spent in the center of the open field chamber for control (n=8) and experimental 
(n=10) mice 
 
Elevated Plus Maze Time in Open Arms 
Figure 1.  Time spent in the open arms of the elevated plus maze for control (n=9) and experimental 
(n=11) mice.   
 
A 
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Figure 6 | Bar graph of percent time freezing 
when presented with fear conditioning cues for 
n=3 mice 
Forced Swim Stress Time  
Immobile (Bar Graph) 
Forced Swim Stress Time 
 Immobile (Scatter Plot) 
Figure 3. Scatter plot (A) and bar graph (B) of percent time spent immobile in FSS cylinder for 
control (n=8) and experimental (n=11) mice.  
 
A B 
A B 
Figure 4. Time spent in the open arms (A) and entries into the open arms (B) of the EPM for control (no 
FSS) and FSS-EPM mice.   
 
 
 
 
FSS-EPM Time in Open Arms FSS-EPM Entries Into Open Arms 
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DISCUSSION 
The results of the study thus far have interesting implications for the role of the 
dynorphin/KOR system in the BNST in mediating the stress response in mice.   
 Cre staining will be used to verify the success of stereotaxic surgeries for the control 
(hChR2) and flex-capase3 mice.  We want to see a lack of Cre stain in the injection site – that is, 
no cell bodies where the caspase was injected.  The protocol is currently being improved to 
ensure accuracy of the stain (data not shown).  Verification of the brains could affect the 
representation of data – that is, some mice shown may be valid while others may prove invalid 
due to unsuccessful apoptosis of dynorphin-Cre neurons. 
The elevated plus maze testing paradigm takes advantage of the natural tendency of mice 
to explore novel environments; mice tend to avoid open areas, especially when they are brightly 
lit, favoring darker, more enclosed spaces (Bailey & Crawley, 2009).  Mice that spend more time 
in the open arms tend to be bolder and are indicative of a less anxious and stressed phenotype.  
FSS-EPM Time in Open Arms (s) 
FSS-EPM Entries Into Open Arms (s) 
Figure 5. Time spent in the open arms (A) of the EPM and entries into the open arms of the EPM 
(B) for DREADD and control mice in the FSS-EPM paradigm.  
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The data in Figure 1 show no differences in the amount of time spent in the open arms between 
the experimental and control groups.  Additionally, no difference was seen in entries into the 
open arms between these two groups (data not shown).  This data alone does not support our 
hypothesis that ablation of dynorphin would cause a less anxious phenotype in the experimental 
mice.  
The open field test provides a way to systematically assess novel environment 
exploration and general locomotor activity and screen for anxiety-related behavior in rodents
 
(Bailey & Crawley 2009).  Mice that spend significantly more time exploring the unprotected 
center area demonstrate anxiolytic-like baseline behavior (Prut & Belzung, 2003).  The data in 
Figure 2 show no significant difference in time spent in the center (and corners) of the open field 
chamber between the experimental mice (without dynorphin) and control mice.  Thus, the open 
field data alone are not telling of the role of the dynorphin/KOR system in mediating the stress 
response. 
In the forced swim stress test, mice typically show exploratory behavior during the first 
two minutes of the test but become quite immobile during the last four minutes of the test (from 
which data are analyzed).  Immobility was originally considered to be evidence that mice had 
learned that escape was impossible and had given up hope (Castagne et al. 2009).  Many 
experiments have since shown that immobility is reduced by a wide range of clinically active 
antidepressant drugs, and the test is now commonly used as a screen for depressive states and 
antidepressant activity (Hascoet & Bourin, 2009).  There is no significant difference seen in 
Figure 3 between the control and experimental groups, indicating that no anxiety or depressive 
phenotype is seen in one group of mice compared to the other. 
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It is important to note that the first two behavioral paradigms – the EPM and open field –
were performed under basal, non-stress conditions, since the EPM and open field tests are not 
particularly stressful.  Since we saw no difference between the experimental and control mice 
under basal, non-stress conditions, we wanted to see whether we could produce a different 
phenotype between our groups under stressful conditions using these same behavioral paradigms, 
since stress-induced activation of the KOR is supported in the literature (Bruchas, Land, & 
Chavkin, 2010).   
To achieve this goal, we ran a cohort of wild-type mice through FSS immediately 
followed by EPM, as described in the methods above.  Here, the control mice did not undergo 
FSS before EPM, while experimental mice were subjected to FSS followed by EPM.  As seen in 
Figure 4, no significant difference was seen between control and experimental mice in time spent 
in the open arms of the EPM, but a statistically significant difference was seen between the 
control and experimental mice in entries into the open arms, with the control mice entering the 
open arms an average of 4.95 more times.  This showed that the FSS test was able to serve as a 
significant stressor in the mouse’s life and caused it to show a more anxious phenotype in the 
EPM as compared to control (no FSS) mice.  This also served as a control to show that we were 
able to produce a stressful phenotype in our lab using the protocol specifications described 
above. 
Next, we wanted to run another round of behavioral assays under these stressful 
conditions using a second technological approach – Designer Receptors Exclusively Activated 
by Designer Drugs (DREADDs).  These DREADDs are special G-protein coupled receptors, and 
the ones we used were Gi-coupled inhibitory receptors.  After being stereotaxically injected with 
these DREADDs or control virus, we ran these mice through a similar round of behavior under 
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stressful conditions (using the FSS-EPM protocol).  Forty-five minutes before each experimental 
mouse was placed in the forced swim cylinder, it was intraperitoneally injected with the inert 
ligand for these receptors, clozapine-N-oxide (CNO), allowing us to specifically lower the 
excitability of dynorphin-Cre neurons in the BNST.  Both control (control virus surgically 
injected) mice and experimental mice (inhibitory DREADD receptor surgically injected) were 
intraperitoneally injected with CNO to control for the stressful injection before behavior; since 
CNO is inert, it had no effect on the surgery control mice and simply served as an injection 
control.  As displayed in Figure 5, there is no significant difference seen between the control (no 
DREADD) and experimental (DREADD) groups in time spent in the open arms of the EPM.  
Interestingly, there is a statistically significant difference between the control and experimental 
groups in entries into the open arms, with the control groups entering the arms 3.4 times more, 
on average.  Notably, the control groups are actually showing the less anxious phenotype here, 
and the DREADDs seem to be having an anxiogenic effect.   
This anxiogenic effect of functionally inhibiting dynorphin in the BNST is the opposite 
effect than what we expected in our hypothesis, and it goes contrary to existing evidence in the 
field.  Importantly, the existing literature deals with the effects of activating and inactivating 
KORs systemically, and here we are only looking at the dynorphin/KOR system in the BNST.  
Our results suggest that functionally inhibiting dynorphin in this region could have an anxiogenic 
effect rather than the expected anxiolytic effect. 
It is important to note that we have a small sample size with this DREADD data, and 
future behavioral assays need to be performed to confirm this effect.  These mice will be run 
through Novelty-Suppressed Feeding and the Light/Dark Box tests to test for a stress phenotype, 
and following these tests, another round of mice will be injected with DREADDs and run 
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through the FSS-EPM, Novelty-Suppressed Feeding, and Light/Dark Box behavioral paradigms 
to increase the sample size.   
Ultimately, the mechanism we are trying to understand is simply one piece of a larger 
puzzle in understanding the circuits underlying the stress response and alcoholism in mice.  
Though we may be moving towards an exciting discovery about the dynorphin/KOR system in 
the BNST, we don’t know exactly where these dynorphin neurons project and what effects they 
might have on downstream brain regions.  Thus, in addition to running more mice through the 
DREADD surgeries and behavioral paradigms discussed above, we will also perform a tracer 
study to see where these dynorphin neurons in the BNST project.  Through all these studies, we 
may take an important step towards understanding the brain circuitry involved in the stress 
response and alcoholism and may eventually inform clinical and pharmacological treatment 
strategies for some of our most pressing public health concerns. 
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